Valneva SE Logo

Valneva SE

Specialty vaccine company developing and commercializing vaccines for infectious diseases.

VLA | PA

Overview

Corporate Details

ISIN(s):
AT0000A10B99 (+3 more)
LEI:
969500DIVIP5VKNW4948
Country:
France
Address:
6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN

Description

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-05-31 07:15
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
English 128.1 KB
2023-05-31 07:00
Valneva Announces the Availability of Documentation for its Shareholder Meeting
English 84.2 KB
2023-05-31 07:00
Valneva annonce la mise à disposition des documents préparatoires à son assembl…
French 116.7 KB
2023-05-30 07:00
Valneva Files for Chikungunya Vaccine Authorization with Health Canada
English 166.9 KB
2023-05-30 07:00
Valneva dépose une demande d'autorisation de mise sur le marché auprès de Santé…
French 173.8 KB
2023-05-04 18:00
VALNEVA - Déclaration d’actions et de droits de vote - 30 avril 2023
French 13.9 KB
2023-05-04 18:00
VALNEVA - Declaration of shares and voting rights - April 30, 2023
English 14.2 KB
2023-05-04 07:00
Valneva publie ses résultats financiers du premier trimestre 2023 et fait un po…
French 400.2 KB
2023-05-04 07:00
Valneva Reports First Quarter 2023 Financial Results and Provides Corporate Up…
English 349.5 KB
2023-04-06 08:00
VALNEVA - Déclaration d’actions et de droits de vote : 31 mars 2023
French 14.0 KB
2023-04-06 08:00
VALNEVA - Declaration of shares and voting rights - March 31, 2023
English 14.3 KB
2023-03-31 07:00
Valneva annonce le dépôt de son Document d’Enregistrement Universel 2022 et de …
French 116.1 KB
2023-03-31 07:00
Valneva Announces Filing of 2022 Universal Registration Document and US Form 20…
English 83.0 KB
2023-03-30 16:33
DEU 2022 VALNEVA
French 24.4 MB
2023-03-30 16:33
DEU 2022 VALNEVA
French 24.4 MB

Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Valneva SE

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Valneva SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-03-18 N/A Other Buy 44,222 N/A
2024-01-03 N/A Other Other 34,802 N/A
2023-06-20 N/A Other Sell 192,547 1,406,228.50 EUR
2023-06-19 N/A Other Sell 30,661 209,629.26 EUR
2023-06-16 N/A Other Sell 85,589 582,493.06 EUR
2023-06-15 N/A Other Sell 28,179 189,503.78 EUR
2023-06-14 N/A Other Sell 228,951 1,519,914.11 EUR
2023-06-13 N/A Other Sell 29,401 187,922.37 EUR
2023-06-12 N/A Other Sell 117,854 733,782.57 EUR
2023-05-10 N/A Other Buy 87,523 N/A

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.